uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted December 01, 2021

FDA Warns Seller of Saffron Supplements

On November 18th, 2021, the FDA issued a warning letter to Saffron Health Sciences following a review of the company's website, social media, and Amazon product listings, which found statements made about the company's products Crocin Rich, Crocin Rich II, and Crocin Rich Plus to be drug claims.

For example, these Crocin supplements were promoted with statements such as "Crocin supplements are designed for...Alzheimer's...Macular degeneration (AMD), diabetic maculopathy" and "Crocin, the unique water-soluble carotenoid with potent...anti-inflammation effects, could be a promising natural agent to boost immune system and body defense against COVID-19."

Crocin Rich Plus and Crocin Rich II were promoted with statements such as "CROCIN RICH II is Good For...Help recovery of nerve and traumatic injury."

(See ConsumerLab's answer to the question: Does saffron really improve vision or prevent age-related macular degeneration? and the Saffron section in our Vision Supplements Review for information about saffron.)

In addition, these products were found to be misbranded because they do not contain adequate directions for their intended use, as required by federal regulations.

For more information, use the link below.

WARNING LETTER: Saffron Health Sciences

See related warnings:

FDA Warns Sanitizer Corporation for Manufacturing and Misbranding Violations

FDA Warns Seller of "CoronaBox" Containing Vitamin D, Probiotics & More for Unsupported Claims

FDA Warns Seller of Omega XL

FDA Warns Seller of Fish Oil, Apple Cider Vinegar, Collagen, and Elderberry Supplements

Seller of Immune Bio Green Cell Warned by FDA

Seller of Vision Supplements Warned by FDA